MedTrace Logo

DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions

NCT05464147 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2023-09-21

No results posted yet for this study

Summary

The aim of the DYNAMITE study is to investigate the (a) acute procedural and (b) 9-month follow-up performance of DynamX Drug-Eluting Coronary Bioadaptor System implantation in complex coronary lesions.

Conditions

  • Coronary Artery Disease
  • Chronic Total Occlusion of Coronary Artery
  • Bifurcation of Coronary Artery
  • Multi Vessel Coronary Artery Disease
  • Long Lesions Coronary Artery Disease

Interventions

DEVICE

DynamX Drug-Eluting Coronary Bioadaptor System

DynamX Drug-Eluting Coronary Bioadaptor System Implantation in Coronary Artery Lesion

Sponsors & Collaborators

  • Istituto Clinico Humanitas

    collaborator OTHER

  • Elixir Medical Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-19
Primary Completion
2024-03-31
Completion
2024-10-31
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05464147 on ClinicalTrials.gov